Aug 20, 2026 10:09AM
Mar 31, 2026 06:19AM
Oct 1, 2024 06:00AM
Nov 4, 2022 04:03PM
Nov 4, 2022 04:01PM
Aug 31, 2021 09:19AM
Mar 16, 2021 01:30PM Ryvu Therapeutics reports financial results for 2020
Feb 18, 2021 04:01PM
Dec 15, 2020 04:16PM
Dec 15, 2020 04:15PM
Nov 5, 2020 04:01PM
Sep 15, 2020 01:01PM
Aug 25, 2020 04:57AM
Aug 19, 2020 09:42AM Gilead shares slide after FDA knocks back rheumatoid arthritis drug
Aug 19, 2020 09:26AM
Aug 19, 2020 06:11AM
Aug 19, 2020 06:10AM
Aug 18, 2020 07:25PM
Jun 10, 2020 12:58PM
Jun 5, 2020 04:02PM
Jun 5, 2020 04:01PM New Analyses of Phase 2 EQUATOR Clinical Program Support Durable Efficacy of Filgotinib in Psoriatic Arthritis
Jun 5, 2020 04:01PM
May 20, 2020 04:03PM
May 20, 2020 04:03PM
May 20, 2020 04:01PM
Jan 29, 2020 02:00AM
Dec 19, 2019 04:30PM
Nov 9, 2019 04:30PM New Data on Filgotinib in Rheumatoid Arthritis (RA) Demonstrate Durable Efficacy and Safety Profile
Nov 9, 2019 04:30PM
Oct 31, 2019 04:46PM
Oct 31, 2019 04:01PM
Oct 31, 2019 04:01PM
Oct 28, 2019 04:45PM
Oct 11, 2019 06:04AM
Oct 10, 2019 06:00PM Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis
Oct 10, 2019 06:00PM
Aug 7, 2019 04:05PM
Jul 25, 2019 04:02PM
Jul 23, 2019 07:00AM
Jul 14, 2019 02:53PM
Jul 2, 2019 01:01AM
Jun 11, 2019 06:10AM Galapagos NV (GLPG), Servier Report Complete Enrollment of Global ROCCELLA Phase 2 Clinical Trial with GLPG1972/S201086
Jun 11, 2019 01:01AM
May 29, 2019 04:31PM
Apr 23, 2019 04:15PM
Apr 23, 2019 04:02PM
Jan 29, 2019 06:22AM
Dec 17, 2018 04:24PM
Dec 17, 2018 04:20PM Galapagos reports initiation of ISABELA Phase 3 program with GLPG1690 in patients with Idiopathic Pulmonary Fibrosis (IPF)
Nov 27, 2018 04:23PM

330,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All